Monensin-mediated growth inhibition in NCI-H929 myeloma cells via cell cycle arrest and apoptosis

  • Authors:
    • Woo Hyun Park
    • Eun Shil Kim
    • Byoung Kook Kim
    • Young Yiul Lee
  • View Affiliations

  • Published online on: July 1, 2003     https://doi.org/10.3892/ijo.23.1.197
  • Pages: 197-204
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Previously, we showed that monensin, Na+ ionophore, potently inhibited the growth of acute myelogenous leukemia and lymphoma cells. Here, we investigated the antiproliferative effect of monensin on human myeloma cell lines. Monensin significantly inhibited the proliferation of myeloma cell lines examined with IC50 of about 1 µM. Cell cycle analysis indicated that monensin induced a G1 and/or a G2-M phase arrest in these cell lines. To address the mechanism of the antiproliferative effect of monensin, we examined the effect of this drug on cell cycle-related proteins in NCI-H929 cells. Monensin decreased the levels of CDK2, CDK6, cdc2, cyclin A, cyclin B1, cyclin D1 and cyclin E proteins but did not alter CDK4 protein. While p21 was increased by monensin, p27 was not. In addition, monensin markedly enhanced the binding of p21 with CDK6 and cdc2. Furthermore, the activities of CDK2- and CDK6-associated kinases were reduced in association with hypophosphorylation of Rb protein. The activity of cdc2-associated kinase was decreased, which was accompanied by reduction of cdc25C phosphatase. Also, monensin induced apoptosis in myeloma cells, as evidenced by annexin V binding assay and flow cytometric detection of sub-G1 DNA content. This apoptotic process was associated with down-regulation of Bcl-2, loss of mitochondria transmembrane potential (Δψm) and an increase of caspase-3 activity. In addition, monensin caused the up-regulation of ERK and p38 kinase activities. Taken together, these results have demonstrated for the first time that monensin potently inhibited the proliferation of human myeloma cell lines, especially NCI-H929 cells, via cell cycle arrest in association with p21 and apoptosis.

Related Articles

Journal Cover

July 2003
Volume 23 Issue 1

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Park, W.H., Kim, E.S., Kim, B.K., & Lee, Y.Y. (2003). Monensin-mediated growth inhibition in NCI-H929 myeloma cells via cell cycle arrest and apoptosis. International Journal of Oncology, 23, 197-204. https://doi.org/10.3892/ijo.23.1.197
MLA
Park, W. H., Kim, E. S., Kim, B. K., Lee, Y. Y."Monensin-mediated growth inhibition in NCI-H929 myeloma cells via cell cycle arrest and apoptosis". International Journal of Oncology 23.1 (2003): 197-204.
Chicago
Park, W. H., Kim, E. S., Kim, B. K., Lee, Y. Y."Monensin-mediated growth inhibition in NCI-H929 myeloma cells via cell cycle arrest and apoptosis". International Journal of Oncology 23, no. 1 (2003): 197-204. https://doi.org/10.3892/ijo.23.1.197